We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Potassium Citrate and Potassium Gluconate Versus Potassium Chloride Experimental Evaluation of Relative Intestinal Toxicity

Scott J. Boley, MD; Leon Schultz, MD; Solomon Schwartz, MD; Armand Katz, MD; Arthur C. Allen, MD
JAMA. 1967;199(3):215-217. doi:10.1001/jama.1967.03120030119028.
Text Size: A A A
Published online


IN LATE 1964 a sudden increase in the occurrence of circumferential ulcerating, stenosing lesions of the small bowel was noted both in Europe and the United States. Lindholmer et al1 in Sweden and Baker et al2 in this country first suggested the association of these lesions with enteri-coated thiazide diuretic potassium chloride preparations. Extensive experimental and clinical investigations3-6 quickly identified enteric-coated potassium chloride as the responsible agent, and led to recognition of perforating areas of necrosis as a more severe form of the same lesion. The mechanism of damage is believed to be the release and absorption of high concentrations of potassium chloride over short segments of small bowel acting upon submucosal and mural veins to produce venous spasm or paralysis. The resultant venous stasis causes segmental hemorrhagic infarction of varying severity with ulceration and stenosis.7

Recognition of this complication of enteric-coated potassium chloride ingestion has


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.